» Articles » PMID: 3926815

Competitive, Enzyme-linked Immunosorbent Assay for Toxic Shock Syndrome Toxin 1

Overview
Specialty Microbiology
Date 1985 Jul 1
PMID 3926815
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

We developed a competitive, enzyme-linked immunosorbent assay for the quantitation of toxic shock syndrome toxin 1 (TSST-1). Polyvalent immunoglobulin G from immunized rabbits was used as the capture antibody, and alkaline phosphatase conjugated to purified toxin served as the indicator enzyme. A standard curve was generated with each experiment, from which the concentration of toxin in culture supernatants was extrapolated. The assay was useful for determining toxin concentrations of 0.03 to 0.5 micrograms/ml, which is a substantial, practical improvement over immunodiffusion methods. Staphylococcal enterotoxins A through E were not significantly cross-reactive in the assay, and staphylococcal protein A did not interfere with quantitation of TSST-1. By testing a variety of staphylococcal strains, we found 100% concordance between toxin determinations made with our assay and those made by the investigators from whom the strains were obtained. The competitive, enzyme-linked immunosorbent assay is a highly reproducible, inexpensive means of determining TSST-1 concentrations and may have broad applicability in the field of toxic shock research.

Citing Articles

Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.

Parsonnet J, Hansmann M, Seymour J, Delaney M, DuBois A, Modern P BMC Infect Dis. 2010; 10:249.

PMID: 20731864 PMC: 2936898. DOI: 10.1186/1471-2334-10-249.


Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women.

Parsonnet J, Goering R, Hansmann M, Jones M, Ohtagaki K, Davis C J Clin Microbiol. 2008; 46(8):2731-8.

PMID: 18550735 PMC: 2519460. DOI: 10.1128/JCM.00228-08.


Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.

Parsonnet J, Hansmann M, Delaney M, Modern P, DuBois A, Wieland-Alter W J Clin Microbiol. 2005; 43(9):4628-34.

PMID: 16145118 PMC: 1234102. DOI: 10.1128/JCM.43.9.4628-4634.2005.


Diversity of toxic shock syndrome toxin 1-positive Staphylococcus aureus isolates.

Warner J, Onderdonk A Appl Environ Microbiol. 2004; 70(11):6931-5.

PMID: 15528567 PMC: 525155. DOI: 10.1128/AEM.70.11.6931-6935.2004.


Method for optimizing pulsed-field gel electrophoresis banding pattern data.

Warner J, Onderdonk A J Mol Diagn. 2003; 5(1):21-7.

PMID: 12552076 PMC: 2216700. DOI: 10.1016/S1525-1578(10)60447-3.


References
1.
Parsonnet J, Hickman R, Eardley D, Pier G . Induction of human interleukin-1 by toxic-shock-syndrome toxin-1. J Infect Dis. 1985; 151(3):514-22. DOI: 10.1093/infdis/151.3.514. View

2.
Fey H, Pfister H, Ruegg O . Comparative evaluation of different enzyme-linked immunosorbent assay systems for the detection of staphylococcal enterotoxins A, B, C, and D. J Clin Microbiol. 1984; 19(1):34-8. PMC: 270973. DOI: 10.1128/jcm.19.1.34-38.1984. View

3.
Robbins R, Gould S, Bergdoll M . Detecting the enterotoxigenicity of Staphylococcus aureus strains. Appl Microbiol. 1974; 28(6):946-50. PMC: 186861. DOI: 10.1128/am.28.6.946-950.1974. View

4.
Ikejima T, Dinarello C, Gill D, Wolff S . Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome. J Clin Invest. 1984; 73(5):1312-20. PMC: 425153. DOI: 10.1172/JCI111334. View

5.
van Miert A, van Duin C, Schotman A . Comparative observations of fever and associated clinical hematological and blood biochemical changes after intravenous administration of staphylococcal enterotoxins B and F (toxic shock syndrome toxin-1) in goats. Infect Immun. 1984; 46(2):354-60. PMC: 261538. DOI: 10.1128/iai.46.2.354-360.1984. View